News
This was the stock's second consecutive day of losses.
Kenvue on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a ...
Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday as strong demand for its cough-and-cold ...
Kenvue Inc. has announced the appointment of Amit Banati as chief financial officer, effective today. He will be responsible ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new ...
Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs.
Explore more
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
The stock's rise snapped a three-day losing streak.
The leadership change comes at the end of a week in which the California-based toymaker landed squarely in the crosshairs of ...
Kenvue Inc. reported second-quarter earnings that surpassed analyst estimates, while updating its full-year 2025 guidance to account for tariffs and currency headwinds.
Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSofya Tsinis - Head of Investor RelationsThibaut ...
Kenvue KVUE1.58%increase; green up pointing triangle, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results